Study of Immune Response in Gynaecological Tumours
Author Information
Author(s): A. Ferguson, M. Moore, H. Fox
Primary Institution: St. Mary's Hospital, Manchester; Christie Hospital and Holt Radium Institute, Manchester
Hypothesis
How do MHC products and leucocyte differentiation antigens express in gynaecological neoplasms compared to normal tissues?
Conclusion
The study found that malignant gynaecological tumours often lack MHC Class I expression, while leucocyte infiltration varies significantly between normal and malignant tissues.
Supporting Evidence
- MHC Class I products were absent in 7 out of 8 ovarian carcinomas.
- Leucocyte infiltration was significantly higher in tumours compared to normal tissues.
- 4 out of 8 endometrial carcinomas expressed MHC Class II antigens.
Takeaway
This study looked at how certain immune markers are present in cancerous tissues compared to normal ones, finding that cancer often hides from the immune system.
Methodology
The study used monoclonal antibodies in an indirect immunoperoxidase technique to analyze tissue samples from patients undergoing surgery.
Limitations
The study had a limited number of tumours examined and a restricted panel of monoclonal antibodies.
Participant Demographics
Patients aged 31-77 years, with samples from normal and malignant tissues of the cervix, endometrium, and ovary.
Want to read the original?
Access the complete publication on the publisher's website